Loading...
Plasma Level of MMP-10 May Be a Prognostic Marker in Early Stages of Breast Cancer
Background: Stromelysins are potential breast cancer biomarkers. The aim of the study was to evaluate if plasma levels of selected metalloproteinases (MMPs) (stromelysin-1 (MMP-3) and stromelysin-10 (MMP-10)) and cancer antigen 15-3 (CA 15-3) used separately and in combination demonstrated diagnosti...
Saved in:
| Published in: | J Clin Med |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
MDPI
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7767367/ https://ncbi.nlm.nih.gov/pubmed/33371324 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9124122 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|